Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Oualla K, El-Zawahry HM, Arun B, Reuben JM, Woodward WA, Gamal El-Din H, et al. Novel therapeutic strategies in the treatment of triple-negative breast cancer. Ther Adv Med Oncol. 2017;9(7):493–511. https://doi.org/10.1177/1758834017711380.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med. 2013;274(2):113–26. https://doi.org/10.1111/joim.12084.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, et al. EMT and tumor metastasis. Clin Transl Med. 2015;4:6. https://doi.org/10.1186/s40169-015-0048-3.

Article  PubMed  PubMed Central  Google Scholar 

Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006;66(17):8319–26. https://doi.org/10.1158/0008-5472.CAN-06-0410.

CAS  Article  PubMed  Google Scholar 

Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009;384(1):6–11. https://doi.org/10.1016/j.bbrc.2009.04.051.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Fearon ER. Cancer: Context is key for E-cadherin in invasion and metastasis. Curr Biol. 2019;29(21):R1140–2. https://doi.org/10.1016/j.cub.2019.09.054.

CAS  Article  PubMed  Google Scholar 

Tang D, Xu S, Zhang Q, Zhao W. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Med Oncol. 2012;29(2):526–33. https://doi.org/10.1007/s12032-011-9948-2.

CAS  Article  PubMed  Google Scholar 

Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, et al. Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer. 2010;103(2):249–55. https://doi.org/10.1038/sj.bjc.6605735.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002;4(3):222–31. https://doi.org/10.1038/ncb758.

CAS  Article  PubMed  Google Scholar 

Liu Z, Wu Y, Tao Z, Ma L. E3 ubiquitin ligase Hakai regulates cell growth and invasion, and increases the chemosensitivity to cisplatin in nonsmallcell lung cancer cells. Int J Mol Med. 2018;42(2):1145–51. https://doi.org/10.3892/ijmm.2018.3683.

CAS  Article  PubMed  Google Scholar 

Rodriguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Aparicio LA, Figueroa A. Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer. 2011;11:474. https://doi.org/10.1186/1471-2407-11-474.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hui LP, Zhang SY, Wudu M, Ren HJ, Xu YT, Zhang QF, et al. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion. Thorac Cancer. 2019;10(6):1479–88. https://doi.org/10.1111/1759-7714.13097.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Castosa R, Martinez-Iglesias O, Roca-Lema D, Casas-Pais A, Diaz-Diaz A, Iglesias P, et al. Hakai overexpression effectively induces tumour progression and metastasis in vivo. Sci Rep. 2018;8(1):3466. https://doi.org/10.1038/s41598-018-21808-w.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, Lan SJ, et al. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res. 2011;21(4):609–26. https://doi.org/10.1038/cr.2011.17.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Aparicio LA, Castosa R, Haz-Conde M, Rodriguez M, Blanco M, Valladares M, et al. Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells. BMC Cancer. 2014;14:507. https://doi.org/10.1186/1471-2407-14-507.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Deep G, Gangar SC, Agarwal C, Agarwal R. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res (Phila). 2011;4(8):1222–32. https://doi.org/10.1158/1940-6207.CAPR-10-0370.

CAS  Article  Google Scholar 

Martinez-Iglesias O, Casas-Pais A, Castosa R, Diaz-Diaz A, Roca-Lema D, Concha A, et al. Hakin-1, a new specific small-molecule inhibitor for the E3 ubiquitin-ligase Hakai, inhibits carcinoma growth and progression. Cancers (Basel). 2020;12(5):1340. https://doi.org/10.3390/cancers12051340.

CAS  Article  Google Scholar 

Kashyap D, Sharma A, Tuli HS, Sak K, Mukherjee T, Bishayee A. Molecular targets of celastrol in cancer: Recent trends and advancements. Crit Rev Oncol Hematol. 2018;128:70–81. https://doi.org/10.1016/j.critrevonc.2018.05.019.

Article  PubMed  Google Scholar 

Liu Z, Ma L, Zhou GB. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules. 2011;16(6):5283–97. https://doi.org/10.3390/molecules16065283.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Shrivastava S, Jeengar MK, Reddy VS, Reddy GB, Naidu VG. Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Exp Mol Pathol. 2015;98(3):313–27. https://doi.org/10.1016/j.yexmp.2015.03.031.

CAS  Article  PubMed  Google Scholar 

Ramamoorthy P, Dandawate P, Jensen RA, Anant S. Celastrol and triptolide suppress stemness in triple negative breast cancer: notch as a therapeutic target for stem cells. Biomedicines. 2021;9(5):482. https://doi.org/10.3390/biomedicines9050482.

CAS  Article  PubMed  PubMed Central  Google Scholar 

You D, Jeong Y, Yoon SY, AK S, Kim SW, Nam SJ, et al. Celastrol attenuates the inflammatory response by inhibiting IL1beta expression in triplenegative breast cancer cells. Oncol Rep. 2021;45:6. https://doi.org/10.3892/or.2021.8040.

CAS  Article  Google Scholar 

Yan F, Wu Z, Li Z, Liu L. Celastrol inhibits migration and invasion of triple-negative breast cancer cells by suppressing interleukin-6 via downregulating nuclear factor-kappaB (NF-kappaB). Med Sci Monit. 2020;26:e922814. https://doi.org/10.12659/MSM.922814.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ma L, Peng L, Fang S, He B, Liu Z. Celastrol downregulates E2F1 to induce growth inhibitory effects in hepatocellular carcinoma HepG2 cells. Oncol Rep. 2017;38(5):2951–8. https://doi.org/10.3892/or.2017.5971.

CAS  Article  PubMed  Google Scholar 

Ma L, Zhu Y, Fang S, Long H, Liu X, Liu Z. Arenobufagin induces apoptotic cell death in human non-small-cell lung cancer cells via the noxa-related pathway. Molecules. 2017;22(9):1525. https://doi.org/10.3390/molecules22091525.

CAS  Article  PubMed Central  Google Scholar 

Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 2009;1796(2):75–90. https://doi.org/10.1016/j.bbcan.2009.03.002.

CAS  Article  PubMed  Google Scholar 

Aparicio LA, Valladares M, Blanco M, Alonso G, Figueroa A. Biological influence of Hakai in cancer: a 10-year review. Cancer Metastasis Rev. 2012;31:375–86. https://doi.org/10.1007/s10555-012-9348-x.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, et al. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother. 2021;141:111824. https://doi.org/10.1016/j.biopha.2021.111824.

CAS  Article  PubMed  Google Scholar 

Yang Z, Zhang Q, Yu L, Zhu J, Cao Y, Gao X. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer. J Ethnopharmacol. 2021;264: 113249. https://doi.org/10.1016/j.jep.2020.113249.

CAS  Article  PubMed  Google Scholar 

Lim HY, Ong PS, Wang L, Goel A, Ding L, Li-Ann Wong A, et al. Celastrol in cancer therapy: Recent developments, challenges and prospects. Cancer Lett. 2021;521:252–67. https://doi.org/10.1016/j.canlet.2021.08.030.

CAS  Article  PubMed  Google Scholar 

Song Y, Ye M, Zhou J, Wang ZW, Zhu X. Restoring E-cadherin expression by natural compounds for anticancer therapies in genital and urinary cancers. Mol Ther Oncolytics. 2019;14:130–8. https://doi.org/10.1016/j.omto.2019.04.005.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Song Y, Ye M, Zhou J, Wang Z, Zhu X. Targeting E-cadherin expression with small molecules for digestive cancer treatment. Am J Transl Res. 2019;11(7):3932–44.

CAS  PubMed  PubMed Central  Google Scholar 

Lin L, Sun Y, Wang D, Zheng S, Zhang J, Zheng C. Celastrol ameliorates ulcerative colitis-related colorectal cancer in mice via suppressing inflammatory responses and epithelial-mesenchymal transition. Front Pharmacol. 2015;6:320. https://doi.org/10.3389/fphar.2015.00320.

CAS  Article  PubMed 

留言 (0)

沒有登入
gif